Carbohydrates are known to play essential roles in various biological processes including development. However, it remains largely unknown which carbohydrate structure takes part in each biological event. Here, we examined the roles of the human natural killer-1 (HNK-1) carbohydrate in medaka embryogenesis. We first cloned two medaka glucuronyltransferases, GlcAT-P and GlcAT-S, key enzymes for HNK-1 biosynthesis. Overexpression of these glucuronyltransferases affected morphogenetic processes. In addition, loss-of-function experiments revealed that GlcAT-P is physiologically indispensable for head morphogenesis and GlcAT-P depletion also led to markedly increased apoptosis. However, even when the apoptosis was blocked, abnormal head morphogenesis caused by GlcAT-P depletion was still observed, indicating that apoptosis was not the main cause of the abnormality. Moreover, in situ hybridization analyses indicated that GlcAT-P depletion resulted in the abnormal formation of the nervous system but not in cell specification. These results suggest that tight regulation of HNK-1 expression is essential for proper morphogenesis of medaka embryos.
Introduction
Glycosylation is one of the major post-translational modifications frequently found in membrane-targeted and secreted proteins. Glycosyltransferases are the enzymes that transfer a monosaccharide unit to an acceptor molecule, and thus are essential for synthesis of carbohydrate chains. Over the past few decades, a considerable number of studies have been carried out to elucidate the roles of specific carbohydrates in various biological processes through manipulation of glycosyltransferase activities (Lowe and Marth 2003; Ohtsubo and Marth 2006) . For example, gene-knockout studies have revealed that each structurally different carbohydrate has a specific function in murine embryogenesis (Metzler et al. 1994) . In many cases, the expression profiles of structurally distinct carbohydrates are known to change dramatically during early development, making a subset of carbohydrates extremely specific and useful differentiation markers (Solter and Knowles 1978) . Among such differentiation marker carbohydrates, human natural killer-1 (HNK-1) is a carbohydrate specifically expressed in the central nervous system in a developmentally regulated manner (Schwarting et al. 1987; Yoshihara et al. 1991) and has a unique structural feature of the sulfoglucuronyl residue at nonreduced terminus of glycan (Chou et al. 1986; Voshol et al. 1996) . Two glycosyltransferases, glucuronyltransferase-P (GlcAT-P) and glucuronyltransferase-S (GlcAT-S), are essential for the biosynthesis of the HNK-1 carbohydrate in vivo (Terayama et al. 1997 (Terayama et al. , 1998 Seiki et al. 1999; Mitsumoto et al. 2000; Yamamoto et al. 2002) . The characteristic expression of the HNK-1 carbohydrate is observed in rhombomeres (Kuratani 1991) and migrating neural crest cells (Bronner-Fraser 1986) in developing mouse embryos, and in chick epiblasts as a salt-pepper-like pattern (Canning and Stern 1988) . In the case of chick epiblasts, it has been shown that the cells containing the HNK-1 carbohydrate are required for gastrulation (Stern and Canning 1990) , indicating that this carbohydrate plays essential roles during embryogenesis. As the HNK-1 carbohydrate is mainly present on cell adhesion molecules and components of the extracellular matrix, it is generally considered to modify the cell-cell and cell-matrix interactions (Saghatelyan et al. 2000; Liedtke et al. 2001) . However, the knowledge about the physiological roles of the HNK-1 carbohydrate in early development, especially at the molecular level, remains very much limited. One of the main reasons for this is that early development in the above-mentioned model organisms is mostly inaccessible, as it takes place either in the uterus or inside an opaque eggshell. To circumvent this problem, here we used a teleost fish medaka as a model, as its early development can be observed in detail without a perturbation of natural developmental processes, and micromanipulation, e.g., gene knockdown and overexpression, can be readily carried out.
In this study, we investigated in detail the functions of the HNK-1 carbohydrate in medaka embryonic development. We first cloned cDNAs encoding two medaka glucuronyltransferases, GlcAT-P and GlcAT-S, and characterized the expression of these GlcATs along with the HNK-1 carbohydrate during early development. In addition, gain-and loss-of-function analyses revealed that the appropriate expression level of the HNK-1 carbohydrate is essential for proper morphogenesis, especially in the head region.
Roles of the HNK-1 carbohydrate in medaka embryogenesis

Fig. 1. Identification and characterization of medaka GlcAT-P and GlcAT-S. (A, C)
Multiple alignment of amino acid sequences of medaka (ol), human (hs), and mouse (mm) GlcAT-P and GlcAT-S. Motifs conserved in all the three species are indicated by asterisks. Blue, yellow, pink, and purple boxes indicate the transmembrane region, potential N-glycosylation sites, residues defining the acceptor substrate specificity and glutamate residue at active site, respectively. Green boxes indicate four highly conserved motifs among species, designated as motifs I-IV. Open box in red indicates DXD motif conserved in most glycosyltransferases. (B, D) Immunoblot analysis for the HNK-1 carbohydrate and GlcATs expression. FLAG-tagged medaka or rat (rn) GlcATs were expressed in COS-1 cells, and the cell lysates were prepared and analyzed by immunoblot using anti-HNK-1 and anti-FLAG antibodies. (E) Unrooted phylogenetic tree analysis of GlcATs from the three species.
Results
Cloning and characterization of medaka glucuronyltransferases required for the biosynthesis of the HNK-1 carbohydrate
As an initial step to determine the roles of the HNK-1 carbohydrate in medaka embryogenesis, we first isolated cDNAs encoding the glucuronyltransferase, a rate-limiting enzyme for the biosynthesis of the HNK-1 carbohydrate. To this end, RT-PCR was carried out using degenerate primers corresponding to conserved amino acid sequences among GlcATs of human, mouse, and fugu origin. This led to the identification of cDNAs encoding a partial protein exhibiting sequence similarity to vertebrate GlcATs. We then performed 5 -and 3 -RACE and finally acquired medaka GlcAT-P and GlcAT-S cDNAs encoding full length ( Figure 1A and C). For GlcAT-P, we cloned the cDNAs of two distinct sequences designated as L-GlcAT-P (longer clone; accession number AB252648) and GlcAT-P (shorter clone; AB252647). We identified single cDNA clone for GlcAT-S (AB252649) . The open reading frames of the L-GlcAT-P, GlcAT-P, and GlcAT-S cDNA comprise 1074, 1002, and 912 base pairs, encoding proteins of 358, 334, and 304 amino acids, respectively. According to the genomic sequence information acquired from the Medaka Ensembl Genome Database, two isoforms of GlcAT-P are generated through alternative splicing, in which an exon encoding a 24 amino acids stretch is only included in the L-GlcAT-P mRNA ( Figure 1A , red letters). The medaka GlcAT-P and GlcAT-S are predicted to contain four exons, and the extra exon included in L-GlcAT-P is located between exons 1 and 2 of GlcAT-P (denoted as exon 1 in Figure 4A ). L-GlcAT-P, GlcAT-P, and GlcAT-S exhibited 80%, 85%, and 67% amino acid identity to the human ortholog of the respective enzymes. Hydropathy analysis of the deduced amino acid sequences suggested that medaka GlcATs have a single transmembrane region ( Figure 1A and C, blue boxes) with type II transmembrane orientation, which is a common feature of most mammalian glycosyltransferases. Medaka GlcAT-Ps and GlcAT-S contain four domains, designated as motifs I-IV, which are highly conserved in GlcATs of various species ( Figure 1A and C, green boxes). We previously reported that in human GlcATs orthologs, Glu284 in GlcAT-P and Glu273 in GlcAT-S are the active sites ( Figure 1A and C, purple boxes), and Phe245 in GlcAT-P and Trp234 in GlcAT-S define the acceptor substrate specificities ( Figure 1A and C, red boxes) (Kakuda et al. 2004; Shiba et al. 2006) . These residues are also precisely conserved in medaka GlcATs. In addition, medaka GlcATs contain a DXD motif, which is conserved widely in UDP-sugar-dependent glycosyltransferases ( Figure 1A and C, red open boxes) (Negishi et al. 2003) . Moreover, there are potential N-glycosylation sites (three sites for GlcAT-Ps and two for GlcAT-S) which are also found in mammalian GlcATs ( Figure 1A and C, yellow boxes) (Terayama et al. 1997; Seiki et al. 1999 ). These structural features indicate that medaka GlcAT-Ps and GlcAT-S cDNAs obtained here encode true orthologs of mammalian GlcAT-P and GlcAT-S, respectively. This notion was supported by the phylogenetic analysis ( Figure 1E ), which confirmed that medaka GlcAT-P and GlcAT-S are more similar to the respective GlcATs of human and mouse origin, but not to GlcAT-I, which is another β-1,3-glucuronyltransferase necessary for the synthesis of glycosaminoglycans (Kitagawa et al. 1998) . Next, we measured the glucuronyltransferase activity of the proteins encoded by the cloned medaka GlcATs. For this purpose, we transfected the expression vectors for each cDNA into COS-1 cells, followed by immunoblot analysis of the cell lysates using anti-HNK-1 antibodies. In agreement with our previous observation (Terayama et al. 1997; Seiki et al. 1999) , transfection of rat GlcATs cDNA into COS-1 cells resulted in the appearance of immunoreactive bands corresponding to from 70 kDa to over 200 kDa, while mock-transfected cells showed no immunoreactivity (Figure 1B and D) . The cells transfected each medaka GlcATs also showed a similar profile of immunoreactive bands (Figure 1B and D) , suggesting that these cDNAs encode proteins with glucuronyltransferase activity in the cells. Together, these observations suggested that the three newly cloned medaka GlcATs are true orthologs of mammalian GlcATs and that each of them encodes RT-PCR analysis of the two GlcAT-P isoforms and GlcAT-S along with β-actin during medaka embryogenesis. The upper bands in the GlcAT-P panels were L-GlcAT-P and in the lower GlcAT-P. (C, D) Immunoblot analysis for the temporal expression pattern of the HNK-1 carbohydrate during embryonic development. (E, F) Frozen transverse section (10 μm) was prepared from 2 dpf medaka embryos at the head and trunk region, respectively, followed by immunohistochemical staining using anti-HNK-1 antibodies. The HNK-1 carbohydrate is mainly expressed in the brain primordium (red arrow in E), eyes (white arrow in E), neural tube (white arrow in F), and muscle primordium (red arrow in F). Bar, 200 μm. the enzymatically active proteins required for the biosynthesis of the HNK-1 carbohydrate in the cells.
Expression pattern of GlcATs and HNK-1 carbohydrate during medaka embryogenesis
We next examined the temporal expression pattern of GlcAT-P and GlcAT-S genes. RT-PCR analysis was carried out using RNAs extracted from whole embryos at various developmental stages as a template. When we investigated the expression level during gastrula stages, the expression of GlcAT-P was barely detected before 15 h post-fertilization (hpf) and observed at the mid-to late gastrula stages (17-21 hpf), and then had disappeared by 100% epiboly (25 hpf), which is the end of gastrulation ( Figure 2A ). The GlcAT-S expression was not detected during this time window. After the completion of gastrulation and epiboly movements, the expression of both GlcAT-P and GlcAT-S was first detected at 2 days post-fertilization (dpf) and continued to increase at least up to 5 dpf ( Figure 2B ). In both time windows, no difference was seen between the expression of longer and shorter splice variants for GlcAT-P (appearing as two bands on the gels). Overall, we found that GlcAT-P was expressed during gastrulation in a temporally restricted manner, and both GlcATs came to be expressed in later stages after 2 dpf. These results suggest that the biosynthesis of the HNK-1 carbohydrate is also briefly upregulated by pulsatile induction of GlcAT-P expression during gastrulation and may lead to modification of proteins taking part in the complex processes of gastrulation. We then examined the expression pattern of the HNK-1 carbohydrate during medaka development. Proteins were extracted from medaka embryos at various stages and immunoblot analysis was performed using anti-HNK-1 antibodies. The bands for proteins carrying the HNK-1 carbohydrate were detected at around 100 kDa as early as 0 hpf ( Figure 2C ). As descried above, GlcAT-P and GlcAT-S mRNAs were not detected at this stage, suggesting the presence of some maternally loaded glycoproteins carrying the HNK-1 carbohydrate. During the process of development, additional bands emerged from gastrula stages onward ( Figure 2C ). As the HNK-1 carbohydrate expression level was very low from gastrulation to 2 dpf, we carried out the control experiment with normal mouse IgM as a primary antibody instead of anti-HNK-1 antibodies to confirm the specificity of these bands. As a result, these bands were not detected in the control experiment (data not shown). We also examined immunoblot analysis using a peroxidase substrate with higher detection sensitivity (see Material and methods) for the proteins from 21 hpf embryos ( Figure 2D ). This revealed that proteins in the around 100-150 kDa range mainly carry the HNK-1 carbohydrate. The results of these and RT-PCR analyses indicate that medaka GlcAT-P, expressed briefly at gastrulation stage, is responsible for the synthesis of the HNK-1 carbohydrate during gastrulation after the mid-blastula transition. We further investigated the localization of the HNK-1 carbohydrate by immunohistochemistry. Frozen sections of medaka embryos at various stages were prepared and stained using anti-HNK-1 antibodies. The expression of the HNK-1 carbohydrate was detected at 2 dpf and was mainly found in the nervous system, e.g., the eye ( Figure 2E , white arrow), brain primordium ( Figure 2E , red arrow), and neural tube ( Figure 2F , white arrow). The muscle primordium was also stained ( Figure 2F , red arrow). These results were consistent with previous reports that the HNK-1 carbohydrate is expressed predominantly in the nervous system in mammals (Schwarting et al. 1987; Yoshihara et al. 1991) . Although the HNK-1 carbohydrate expression was observed on immunoblot analysis, it was not detected by immunostaining in the embryos before 2 dpf (data not shown). The reason for this is currently unclear, but we believe that the HNK-1 carbohydrate expressed a very low level at the stages earlier than 2 dpf (Sadaghiani and Vielkind 1990) . In adult medaka, GlcATs and HNK-1 carbohydrate were expressed mainly in the brain, eye, and muscle (data not shown).
Proper expression of GlcAT-P and HNK-1 carbohydrate is necessary for medaka development
The characteristic expression patterns of GlcAT-P and HNK-1 carbohydrate in early medaka embryos imply that they may play important roles in these developmental processes. To analyze the possible functions of the HNK-1 carbohydrate during embryogenesis, we performed gain-and loss-of-function analyses of GlcAT-P and GlcAT-S. We first carried out gain-of-function experiments to see if an excess amount of HNK-1 carbohydrate affects the development of medaka embryos. To this end, we injected in vitro synthesized RNA (100-500 pg) encoding GlcAT-P or GlcAT-S fused with a 6× Myc tag into one-to two-cell stage embryos. When observed at 2 dpf, abnormalities in the head regions were detected at the amount of more than 250 pg GlcAT-P RNA and 100 pg GlcAT-S RNA, respectively. In the case of the embryos injected with 500 pg GlcAT-P RNA, the head region was laterally curved from the body axis of the trunk region ( Figure 3B ). When the same amount of GlcAT-S Fig. 3 . Gain-of-function analysis of GlcAT-P or GlcAT-S in medaka embryos. GlcATs mRNA was injected into one-to two-cell stage embryos, and the phenotypes were observed at 2 dpf. Dorsal view, anterior is to the top. (A) Non-treated wild-type embryos at 2 dpf. (B) The embryos injected with 500 pg GlcAT-P RNA showed slight curvature at the head region. (C) The embryos injected with 500 pg GlcAT-S RNA showed more severe defects such as curved head and shortened body axis. In spite of severe head hypoplasia, these embryos still retained the eye-like structure (arrows). (D, E) Immunoblot analysis for the HNK-1 carbohydrate and GlcAT-P expression. Non-treated wild-type and GlcAT-P RNA-injected embryos were lysed, and the lysates were analyzed using anti-HNK-1 or anti-Myc antibodies. Bar, 200 μm.
RNA was injected, it resulted in more severe phenotype, i.e., the curvature of the heavily disorganized head region as to the body axis was greater, and the trunk region also appeared to be shorter ( Figure 3C ). In addition, when 250 pg GlcAT-S mRNA was injected, the embryos showed similar phenotypic severity to the embryos injected with 500 pg GlcAT-P RNA (data not shown). For investigation of the influence of RNA injection, we injected with 500 pg EGFP RNA. As a result, these embryos developed normally (supplementary Figure 1B and C) . To make sure that the injection of GlcATs RNA indeed led to the ectopic expression of this enzyme and HNK-1 carbohydrate, immunoblot analysis with anti-Myc and anti-HNK-1 antibodies were performed for the lysates obtained from embryos at 2 dpf. We detected the Myc-tagged GlcATs protein and an increased level of the HNK-1 carbohydrate in the injected embryos, suggesting that the injection of GlcATs RNA at the one-to two-cell stage actually increased the GlcATs activity, leading to an increase in the HNK-1 carbohydrate as late as 2 dpf ( Figure 3D and supplementary Figure 1A) . Overall, the overexpression of the GlcATs induced the abnormal development of medaka.
Next, we carried out loss-of-function analyses using antisense morpholino oligonucleotides (MOs) specific to medaka GlcATs. MO has been used to inhibit target gene functions with high efficiency and specificity in medaka embryos. In this study, we employed two MOs for GlcAT-P, P-MO-1 and P-MO-2 ( Figure 4A , red and blue lines, respectively), and one MO for GlcAT-S, S-MO (see Material and methods). P-MO-1 and S-MO are translation-blocking morpholinos, which bind to the target site including the start codon, while P-MO-2 is a splice-blocking morpholino, which binds to the target region spanning the junction between the third intron and fourth exon (i.e., exon 3) D Anzai et al. Fig. 4 . Efficient inhibition of GlcAT-P activity by morpholino oligonucleotides. (A) Schematic representation of the exon-intron structures of the GlcAT-P gene. The locations of target sequences for P-MO-1 and P-MO-2 were indicated by a red and a blue bar, respectively. Arrows indicate the primers used for RT-PCR in panel E. The box is included only in the longer variant of GlcAT-P. (B) Schematic representation of the construct used to confirm the sequence specificity of P-MO-1. The construct contained medaka GlcAT-P cDNA including a short segment of the 5 -untranslated region, fused in the frame with the sequence of EGFP. (C) Dorsal view of embryos at 1 dpf (st. 18), anterior is to the top. Either control MO or P-MO-1 was co-injected with GlcAT-P-EGFP RNA at one-to two-cell stage. P-MO-1 significantly inhibited EGFP expression while control MO did not affect EGFP expression. Bar, 200 μm. (D) Immunoblot analysis of lysate from P-MO-1-or control MO-injected embryos at 2 dpf. (E) RT-PCR analysis revealed that GlcAT-P transcripts were reduced by the injection of P-MO-2, but not control MO.
( Figure 4A , line). As a control, MOs containing a five-base mismatch as to the respective target site were used. From the results of these MOs injection, GlcAT-S-depleted embryos developed normally (see Table I ), so we analyzed only GlcAT-P-depleted embryos as described below.
To examine the sequence specificity of P-MO-1, we injected P-MO-1 together with RNA encoding GlcAT-P fused to EGFP into medaka embryos ( Figure 4B ). When the control MO was co-injected, EGFP fluorescence was clearly observed in the embryonic body of 1 dpf embryos ( Figure 4C, left) . In contrast, when P-MO-1 was co-injected, fluorescence was not detected, indicating that P-MO-1 blocks the translation of the fusion protein ( Figure 4C , right). We also examined sequence specificity of S-MO by co-injection with S-MO and RNA encoding GlcAT-S fused to EGFP in a similar manner of GlcAT-P. As a result, S-MO also had the sequence specificity against GlcAT-S (data not shown). Moreover, the amount of endogenous proteins carrying the HNK-1 carbohydrate was dramatically reduced in P-MO-1-injected embryos ( Figure 4D ). Thus, P-MO-1 has competence to inhibit GlcAT-P expression when injected into medaka embryos. On the other hand, MOs targeting exon-intron junctions are known to reduce the amount of the mature transcript and inhibit the function of the target gene product. We injected P-MO-2 or its control MO into medaka embryos and examined the amount of the properly spliced GlcAT-P transcript by RT-PCR, finding that P-MO-2 injection led to a marked reduction in the GlcAT-P transcript at 2 dpf ( Figure 4E ). Both P-MO-1 and P-MO-2 are effective in blocking the function of the two isoforms of GlcAT-Ps, L-GlcAT-P and GlcAT-P, as the target sequences of these MOs are located in the common part of these two splice variants (see Figure 4A ). These results demonstrated that two independent MOs against GlcAT-P designed were useful tools for investigating the physiological function of GlcAT-P during medaka embryonic development.
We thus injected the P-MO-1 or control MO into oneto two-cell stage embryos and observed the external appearance of injected embryos at the 75% epiboly stage (21 hpf) ( Figure 5A , B, E, F, J, and K, arrowheads indicate embryonic body edges) and 2 dpf (Figure 5C, D, G, H, I , L, and M). At the 50-75% epiboly stages (mid-gastrula stages), abnormalities of P-MO-1-injected embryos were first observed. Cells around the embryonic body, which was thought to be a presumptive neuroectoderm, were appeared to be darker in color and round shapes compared to control MO-injected ones (compare Figure 5A and B to E and F) . The appearance of the dark colored region in the P-MO-1-injected embryos could be due to enhanced apoptosis (compare Figure 6) . At this stage, the shorter anterior-posterior length was observed in P-MO-1-injected embryos ( Figure 5E ). At 2 dpf, control embryos clearly showed two distinct eyes on the sides of the apparent brain structure ( Figure 5C ) and well-patterned somites ( Figure 5D ). The injection of P-MO-1 induced a spectrum of phenotypic abnormalities with the head hypoplasia, while the trunk region was less affected (Figure 5G-I) . We classified the phenotypes of P-MO-1-injected embryos into two groups according to the severity of the abnormalities. In the mildly affected group (Table I, 23% 
Embryos were injected control MO with a five-base mismatch or two GlcAT-P and one GlcAT-S specific MO into one-to two-cell stage. P-MO-1 and S-MO are translation blocking morpholinos and P-MO-2 is a splicing blocking morpholino. The phenotypes of P-MO-injected embryos were classified into two groups according to the severity of the abnormalities at 2 dpf. Given is the absolute number of embryos, and the percentages are in parentheses.
Roles of the HNK-1 carbohydrate in medaka embryogenesis of P-MO-1-injected embryos), head hypoplasia was observed, although two eyes were still recognizable (an example shown in Figure 5G , an arrow indicates the forming eyes). In these embryos, the organogenesis of the head region seemed to be defective, as the whole head structure was smaller than that in control embryos (compare Figure 5C and G). Somitegenesis did take place in these embryos, although the size and number of somites were reduced and the anterior-posterior length of the embryos seemed to be shorter than that in the control (Figure 5D and H). In the severely affected group (Table I, 42% of P-MO-1-injected embryos), defects in the head organogenesis were much more evident and the eyes were no longer recognized ( Figure 5I ). Moreover, the trunk region appeared to be degenerated in this group of the embryos, although a sign of somitogenesis was still observed. These results demonstrated that the HNK-1 carbohydrate synthesized by GlcAT-Ps plays essential roles in embryonic organogenesis, especially in the head region. The injection of P-MO-2 essentially gave the same result as P-MO-1 injection, albeit there was higher penetrance even at a lower dose (Table I ; abnormal in 65% of the embryos by 5 ng P-MO-1 injection, in contrast to 74% on 1 ng P-MO-2 injection). We further examined whether the phenotypes induced by the injection of P-MO-1 could be reversed by co-expression of GlcAT-P. We synthesized RNA for GlcAT-P that lacks target sequences of the P-MO-1 but still has the ability to synthesize the HNK-1 carbohydrate and co-injected it along with P-MO-1. The injection of the various amount of GlcAT-P RNA did not reverse the defect of development (data not shown), allowing us to surmise that the ectopic expression of GlcAT-P itself causes severe developmental defects (as shown above).
While analyzing the effect of GlcAT-P depletion on early development, we noticed the appearance of dark-stained cells around the presumptive neuroectoderm during gastrulation and the head region at 1-2 dpf in GlcAT-P-depleted embryos (see Figure 5 ). As this could be a sign of apoptotic cell death, we carried out two different assays to detect apoptotic cells, TUNEL staining and acridine orange whole mount staining, of the embryos at both stages. As expected, massive ectopic apoptosis was observed in the regions of GlcAT-P-depleted embryos where the dark-stained cells were observed, whereas no significant staining was seen in control embryos with either assay methods ( Figure 6A -F and data not shown). These results raised the possibility that the defective head morphogenesis observed in GlcAT-P-depleted embryos is caused by the enhanced apoptosis. We thought GlcAT-P depletion specifically resulted in the apoptosis, however it has been reported that apoptosis in the head region was often caused by off-targeting effects of MO (Robu et al. 2007) . To examine this, we investigated whether or not the phenotypic outcome observed in GlcAT-P-depleted embryos was altered when the apoptosis was blocked. For this purpose, we used MO against p53 for inhibiting apoptosis as previously reported (Robu et al. 2007) . Unfortunately, p53 MO we used affected embryonic development by itself at various doses. These results suggested that p53 is more essential for medaka embryonic development than zebrafish. Alternatively, we co-injected RNA encoding Bcl-xL, a well-known inhibitor of apoptosis (Gibson et al. 1996) , with P-MO-1 (Erickson et al. 1989) . As a result, the injection of 250-500 pg of Bcl-xL RNA with P-MO-1 led to the disappearance of the dark-stained cells at both the gastrula stage and 1-2 dpf ( Figure 5J -L, compare with Figure 5E -G). The blockade of the apoptosis by Bcl-xL was further confirmed by TUNEL staining (Figure 6G-I) . In spite of the effective inhibition of the enhanced apoptosis, these embryos still retained the morphogenetic defects characteristic of GlcAT-P-depleted embryos such as the head hypoplasia at 2 dpf ( Figure 5L ). The injection of Bcl-xL RNA alone at both doses did not affect the development at all the stages examined. In view of these results, we thought that the ectopic apoptosis was not caused by off-targeting effects but might be caused by HNK-1 carbohydrate reduction. Therefore, we concluded that the strict regulation of HNK-1 carbohydrate expression through modulation of GlcAT-P expression is essential for organogenesis, especially in the head region, during early medaka development.
Molecular marker analysis of GlcAT-P-depleted embryos
As shown above, the most prominent phenotypic abnormality observed in GlcAT-P-depleted embryos was the head hypoplasia. To gain further insights into the cause of this defect, we performed molecular marker analyses involving in situ hybridization.
It has been well established that the induction of neural tissue requires the function of an organizer (Spemann and Mangold 1924) . We thus examined the expression of chordin (chd), an established marker for the organizer. The expression of chd was detected to the same degree at mid-gastrulation (17 hpf) in both control and GlcAT-P-depleted embryos (data not shown), indicating that the functional organizer was established in the absence of GlcAT-P activity. After being specified to become the neuroectoderm, the cells in the anterior region receive signals from the prechordal plate mesendoderm, which is demarcated by goosecoid (gsc) expression, to develop into the brain structure (Cho et al. 1991) . Hence, we examined the expression pattern of gsc at the late gastrulation stage (21 hpf, Figure 7A ). In GlcAT-P-depleted embryos, the size of the gsc expression domain was essentially similar to that in control embryos, suggesting that the prechordal plate was properly formed in the GlcAT-P-depleted embryos.
Next, in order to examine neural patterning, the expression of otx2 which marks the central nervous system including the forebrain was investigated at the late somite stage (2 dpf). As expected from the morphological analysis shown in Figure 5 , the otx2 expression domain was more greatly reduced in GlcAT-P-depleted embryos than in control ones as early as this stage, although it was not completely abolished even in the severely affected embryos ( Figure 7B ). The specific impairment in the formation of the brain structure was further confirmed by analyzing fgf8 expression, which marks the anterior tip of the forebrain and the midbrain-hindbrain boundary (MHB) in the central nervous system and tail bud mesoderm. When compared with control embryos, GlcAT-P-depleted ones showed marked reduction in the fgf8 expression domains in both the forebrain and MHB, although the expression in the tail bud was unaffected ( Figure 7C) .
Furthermore, we investigated if the trunk mesoderm was properly specified in GlcAT-P-depleted embryos. The expression of a notochord marker, shh, appeared to be unaffected even in the severely affected group of GlcAT-P-depleted embryos (data not shown). In addition, the expression of myoD, a marker for somite was also examined at 34 hpf (somite stage). In the embryos of the mildly affected group, myoD was expressed in somites as in control embryos ( Figure 7D ). Meanwhile, in the severely affected group, its expression was only faintly visible or undetected (data not shown). These results suggested that GlcAT-P-depleted embryos were mainly affected in the head region and most severely affected embryos were also affected in the trunk region.
Finally, we investigated the region in which HNK-1 carbohydrate expression was known to be observed. In the central nervous system, HNK-1 carbohydrate is also expressed in rhombomeres 3 and 5 (r3 and r5) in chick embryo (Kuratani 1991) , both of which are demarcated by krox20 expression ( Figure 7E ). As a result of examination, GlcAT-P-depleted embryos retain the krox20 expression at 34 hpf, though the distance between r3 and r5 became shorter in mildly affected embryos at the early somite stage ( Figure 7E, upper-right panel) . In severely affected embryos, however, only one domain exhibiting krox20 expression was seen at this stage ( Figure 7E , lower-right panel). Since GlcAT-P-depleted embryos showed impaired brain formation, it was unclear which rhombomere was lost. Alternatively, it is also possible that the two rhombomeres placed too close and fused with each other. Other physiologically important HNK-1 carbohydrate expressing domains are neural crest cells, shown in many species including teleost fish and mammals (BronnerFraser 1986; Erickson et al. 1989; Sadaghiani and Vielkind 1990) . The HNK-1 carbohydrate is known to play an active role in migration of neural crest cells. For example, in the pax6 mutant mouse, ectopically expressed HNK-1 carbohydrate perturbs migration of the midbrain neural crest cells (Nagase et al. 2001) . To visualize neural crest cells, we investigated the expression of a neural crest marker, sox10, at the early somite stage ( Figure 7F ). In control embryos, sox10 expression was observed on both lateral sides of the embryonic body at 34 hpf, whereas it was confined to one smaller region in the severely affected group of GlcAT-P-depleted embryos ( Figure 7F , lower-right panel). In the embryos with milder phenotypes, two expression domains were detected as in control embryos ( Figure 7F , upper-right panel). These results suggest that the proliferation and/or migration of the neural crest cells were affected, although the specification did take place in the absence of the HNK-1 carbohydrate. In addition, we performed molecular marker analyses for embryos co-injected P-MO-1 and Bcl-xL RNA and we obtained essentially same results compared to GlcAT-P-depleted embryos (supplementary Figure 1D and E).
Taken together, the molecular marker analyses demonstrated that the formation of the anterior neural structures, including the brain and neural crest, was compromised in GlcAT-P-depleted embryos even though the organizer and prechordal plate were properly formed. This may indicate that these defects were caused either by the proposed enhanced apoptosis of the ectodermal cells or by failure of these cells to respond properly to patterning signals released from the prechordal plate. The mesoderm in the trunk/tail region was largely unaffected in these embryos.
Discussion
In this study, we used medaka as a model organism to elucidate the function of HNK-1 in early development. We first cloned cDNAs encoding medaka GlcAT-P and GlcAT-S, which retain high sequence similarity to their human and mouse orthologs ( Figure 1A and C). For GlcAT-P, we found two splice variants, which have not been reported in other species so far. We next examined the expression pattern of these enzymes during medaka embryogenesis. GlcAT-P expression was observed in a temporally restricted manner during gastrulation, followed by a second phase of expression after 2 dpf (Figure 2A and B) . In contrast, GlcAT-S exhibited a simple expression pattern, being expressed only after 2 dpf (Figure 2A and B) . The expression patterns of these two enzymes indicate that GlcAT-P, but not GlcAT-S, is the enzyme responsible for HNK-1 carbohydrate synthesis during early embryogenesis. Unfortunately, we did not obtain the significant results about the spatial expression pattern of GlcATs by in situ hybridization, presumably because of their low-level expression, as is true of most glycosyltransferases. We observed a few bands of HNK-1 carrier proteins as early as just after fertilization ( Figure 2C ). As the transcripts for both GlcATs were not detected before the gastrula stage, the HNK-1 carbohydrate observed at one-to two-cell stages were likely carried by maternally loaded proteins. In addition to these bands, other bands of HNK-1 carbohydrate carrier proteins appeared from 21 hpf to 2dpf although the expression level was low ( Figure 2C and D) .
To investigate the function of the GlcATs and HNK-1 carbohydrate during embryogenesis, we next performed gain-and loss-of-function analyses. Overproduction of the HNK-1 carbohydrate by excess GlcATs disturbed early developmental processes (Figure 3) . Interestingly, the injection of GlcAT-S RNA had a more severe effect than GlcAT-P RNA. We previously reported that GlcAT-S is able to recognize the lacto-N-biose (Galβ1-3GlcNAc) structure as well as N-acetyllactosamine (Galβ1-4GlcNAc) as a terminal acceptor, while GlcAT-P strictly recognizes the N-acetyllactosamine structure. Therefore, this broader substrate specificity might cause more severe phenotypes observed in GlcAT-S RNA-injected embryos, as it would lead to more widespread overrepresentation of the HNK-1 carbohydrate on various proteins.
In loss-of-function analyses, we found that GlcAT-P is essential for proper embryogenesis, especially in the head region ( Figure 5 ), while knockdown of GlcAT-S did not affect medaka embryonic development at all (Table I) . Together, these gain-and loss-of-function analyses indicate that an appropriate level of GlcATs activity is critical for proper medaka embryogenesis. In agreement with this notion, co-injection of GlcATs RNA apparently could not rescue completely the phenotypic abnormalities caused by GlcAT-P depletion (data not shown).
We observed massive apoptotic cell death in the neuroectoderm of GlcAT-P-depleted embryos at the mid-gastrulation stage (Figure 7) . In normal medaka embryos, apoptotic cell death becomes evident in the central nervous system and tail bud at the early somite stage (Iijima and Yokoyama 2007) . Therefore, the apoptosis observed in GlcAT-P-depleted embryos is different from normal development in terms of both timing and location. Recently, it was reported that MOs injection often resulted in apoptosis in the neural region by the off-targeting effects. To eliminate this possibility, we co-injected Bcl-xL RNA, which is another well-known inhibitor of apoptosis (Robu et al. 2007 ), together with P-MO-1. With this experimental set-up, the ectopic apoptosis was almost completely blocked. However, the defects in the head morphogenesis were essentially preserved (see Figure 5L ). We concluded that even though enhanced ectopic apoptosis occurs when GlcAT-P activity was depleted, there is a separate cause for the morphogenetic defect. It is well known that when cells lose the appropriate adhesion with other cells and/or extracellular matrix, they undergo apoptotic cell death (Boudreau et al. 1995; Day et al. 1999; Murray and Edgar 2000) . Thus, because the HNK-1 carbohydrate is known to mainly exist on cell adhesion molecules and extracellular matrix proteins, it is possible that impaired adhesiveness of GlcAT-P-depleted cells leads to the ectopic apoptosis. In this point of view, we have tried to perform transplantation experiments (data not shown) to investigate the cause of defects in GlcAT-P-depleted embryos. From the results, we suggest that the adhesiveness or migration was D Anzai et al.
affected in GlcAT-P-depleted embryos. However, it still needs detailed examination.
In situ hybridization analyses for various differentiation markers demonstrated that depletion of GlcAT-P affected the formation of anterior neural structures with less disturbance of the trunk/tail region ( Figure 7) . As the expression of the neuroectodermal marker was reduced while a prechordal plate marker, gsc, was properly maintained in GlcAT-P-depleted embryos ( Figure 7A ), these abnormalities might be somehow caused by impaired transduction of a differentiation/maturation signal emanating from the axial mesendoderm toward the neuroectoderm. In addition, from the results of in situ hybridization with krox20 and sox10, regions that were known to express the HNK-1 carbohydrate were affected, suggesting the functional importance of the HNK-1 carbohydrate in these regions.
Previously, we reported the phenotype of GlcAT-P knockout mice. The knockout mice were born with no obvious abnormalities but the adult knockout mice exhibited reduced long-term potentiation (LTP) at the Schaffer collateral-CA1 synapses and defects in spatial memory formation (Yamamoto et al. 2002) . In contrast, the GlcAT-P-depleted medaka exhibited the defective head morphogenesis and enhanced apoptotic cells in early development as described above. At present, it is difficult to explain why the difference occurred. However, it is possible that another gene such as GlcAT-S might compensate for the loss of GlcAT-P activity in mouse during early development while it might not be present in medaka. In fact, GlcAT-S was not expressed in the early developmental stage in medaka (Figure 2A ).
In conclusion, we identified two medaka β-1,3-glucur onyltransferases required for HNK-1 carbohydrate biosynthesis and analyzed their functions in the context of embryonic morphogenesis. Gain-and loss-of-function analyses of these two GlcATs revealed that production of an appropriate level of the HNK-1 carbohydrate is essential for proper medaka embryogenesis. The loss of GlcAT-P led us to enhance ectopic apoptosis in the neuroectoderm at the mid-gastrulation and the head region at late stages and abnormal morphogenesis in the head region. Further study is necessary to elucidate the molecular mechanisms by which loss of GlcAT-P activity leads to abnormal nervous system formation.
Materials and methods
Strain and maintenance of medaka
In the present study, all the medaka was one inbred line d-rR. Embryos were incubated at 26
• C, and the developmental stages were scored as previously described (Iwamatsu 2004) .
SDS-PAGE and immunoblot analysis
Staged whole embryos or tissues from adult fish were homogenized in Iwamatsu's ringer solution (Iwamatsu 1983) and then centrifuged at 17,000 × g for 10 min at 4
• C. The precipitate was washed by being resuspended in Iwamatsu's ringer solution and centrifuged several times, and then dissolved on ice in phosphate-buffered saline (PBS) containing 0.5% SDS and protease inhibitors (Nacalai Tesque, Kyoto, Japan). Samples were sonicated and centrifuged at 17,000 × g for 20 min at 4
• C. Proteins from each supernatant (20 μg protein for 21 hpf and 1 and 2 dpf embryos or 5 μg protein for 0, 4, and 6 dpf embryos) were resolved on a 5-20% gradient gel by SDS-PAGE (Laemmli 1970) and then transferred to nitrocellulose membranes. After blocking with 5% nonfat dried milk in Tris-buffered saline (TBS), the membranes were incubated with anti-HNK-1 antibodies (American Type Culture Collection), purified mouse myeloma IgM (ZYMED, San Francisco, CA), or anti-Myc antibodies (Calbiochem, Darmstadt, Germany), followed by horseradish peroxidase-conjugated goat anti-mouse IgM antibodies or anti-mouse IgG antibodies, respectively. Protein bands were visualized with ECL or SuperSignal West Femto and West Pico (Pierce, Rockford, IL) using a Luminoimage Analyzer LAS-3000 (Fuji, Tokyo, Japan).
Cloning of medaka GlcAT-P and GlcAT-S, and RT-PCR analysis
The sequences of degenerate primers used for the cloning were designed to cover relatively conserved regions in GlcATs of human, mouse, and fugu. RNA was prepared from medaka embryos with the TRIzol reagent (Invitrogen, Carlsbad, CA) and then reverse transcribed. PCR was then carried out using the degenerate primers designed as above to obtain partial cDNA fragments encoding proteins exhibiting sequence similarities to other vertebrate GlcATs. We then carried out 5 -and 3 -RACE using a SMART-RACE cDNA amplification kit (BD Biosciences, Franklin Lakes, NJ) according to the manufacturer's protocol, and cloned cDNAs encoding the full-length GlcAT-P and GlcAT-S proteins. Phylogenetic analysis of GlcATs was performed with a multiple alignment program ClustalW. The sequences used were hsGlcATs (Homo sapiens, GlcAT-P AB029396, GlcAT-S AY070019, and GlcAT-I AB009598, respectively) and mmGlcATs (Mus musculus, GlcAT-P AB055781, GlcAT-S AB055902, and GlcAT-I AK146264, respectively). The primer sequences used for RT-PCR analyses were (upstream and downstream): 5 -GAAGAGATATTCTTGCCATCGTACT-3 and 5 -GAGCCAGATTCCTCTGCATC-3 or 5 -GCAATTCCC CGAAGAGAAGAGATATTCT-3 and 5 -GATATCTCAAA TCTCCACGTTTGGGT-3 for GlcAT-P; 5 -GCCCTGCC GATGATCTACGCCATCA-3 and 5 -TATGCTCGGCCACC CACAAATCCCA-3 or 5 -TCCTCCTGCCTTGGATCCT-3 and 5 -GGTGCTTCGCATCTCCTCAA-3 for GlcAT-S; 5 -ACCCACACAGTGCCCATCTACGA-3 and 5 -AGACAGCA CAGTGTTGGCGTACAG-3 for β-actin, respectively.
Biosynthetic activity of medaka GlcATs toward the HNK-1 carbohydrate
A truncated GlcAT cDNAs lacking the start codon were amplified by PCR. The primer sequences used were: 5 -GGAATTCCCCGAAGAGAAGAGATATTC-3 and 5 -GATATCTCAAATCTCCACGTTTGGGT-3 for GlcAT-P; and 5 -GGAATTCCAAATCAGTGTTTTTGAGCCG-3 and 5 -GATATCTCACACCTCGATGAGCACCG-3 for GlcAT-S. Each sense primer contains an in-frame EcoRI site and each antisense primer contains an EcoRV site located at 3 downstream of the stop codon. The amplified fragments were subcloned into the EcoRI-EcoRV sites of p3xFLAG-CMV-10 (Sigma-Aldrich, St Louis, MO). The plasmid was transfected into COS-1 cells on 100 mm plates using FuGene6 (Roche, Basel, Switzerland). The transfected cells were harvested for immunoblot analysis
